F-18-fluorodeoxyglucose-positron emission tomography in the evaluation of head and neck cancer: Own results and literature review;F-18-Fluorodeoxy-Glukose-Positronenemissions-Tomographie in der abklärung von tumoren im HNO-bereich: Eigene ergebnisse und literaturübersicht

Wiener Medizinische Wochenschrift

Volumn 152, Issue 11-12, 2002, Pages 259-264

  Kresnik, E ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Conventional imaging methods; F 18 Fluorodeoxyglucose positron emission tomography (F 18 FDG PET); Head and neck cancer; Restaging; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; ADJUVANT THERAPY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; PATHOLOGY; PROGNOSIS; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035984671     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-258X.2002.02018.x     Document Type: Article

References (45)

1. Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors
2. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
3. Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy- 2[F-18]-fluoro-D-glucose PET and MRI imaging diagnoses
4. Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy
5. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients
6. FDG PET detection of unknown primary tumors
7. Detection of unknown primary head and neck tumors by positron emission tomography
8. Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, colour-coded duplex sonography) with panendoscopic and histopathologic findings
9. The impact of radiologic imaging on staging of cancer of the head and neck
10. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck
11. MRI imaging part I. Initial evaluation
12. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiations
13. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?
14. Uses and limtations of FDG positron emission tomography in patients with head and neck cancer
15. CT and MR appearance of recurrent malignant head and neck neoplasm after resection and flap reconstruction
16. Dual time point fluorine-18fluorodeoxyglucose positron emission tomography: A potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
17. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation
18. Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma
19. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F18 in a routine clinical setting
20. 18F-FDG PET: A comparison with conventional methods
21. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumors (UPT)
22. Head and neck cancer: Detection of recurrence with PET and [F-18]fluoro-2-deoxy-D-glucose
23. Comparison of fluorine-18-fluorodeoxyglucose PET. MRI and endoscopy for staging head and neck squamous-cell carcinomas
24. Cervical metastases from unknown primaries: Radiotherapeutic management and appearance of subsequent primaries
25. Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) in the diagnosis and preoperative staging of head and neck tumors: A prospective study
26. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary side
27. Positron emission tomography in the evaluation of laryngeal carcinoma
28. Detection of cervical metastasis: A meta-analysis comparing computed tomography with physical examination
29. Preoperative identification of benign versus malignant parotid masses: A comparative study including positron emission tomography
30. Limitations of parotid scans
31. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer
32. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI
33. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin
34. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers
35. The role of positron emission tomography in occult primary head and neck cancers
36. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis
37. Early detection in the upper aerodigestive tract, part I
38. Magnetic resonance tomography and computerized tomography in tumor staging of mouth and oropharyngeal cancer
39. The value of nuclear magnetic resonance tomography in tumor staging of laryrtgeal-/hypopharyngeal cancer
40. Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI
41. The detection of local and recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography
42. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18 fluorodeoxyglucose positron emission tomography
43. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography
44. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma
45. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT